Free Trial: Direct Access to ValuEngine Research on over 5,000 stocks and 700 ETFs HERE ...

Markets closed the week with measured gains across major equity ETFs, even as geopolitical tensions escalated and volatility expectations rose sharply.

Markets ended the week on a broadly positive note, closing out the third quarter with strength in technology, healthcare, and small caps. The first three quarters of 2025 are now complete, and markets ...

Market action last week depended heavily on where investors chose to look. Beneath largely unchanged headline index levels, sharp rotations continued across style, size, and geography. Value stocks ...

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...

ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...

ValuEngine lowered its rating on Surgery Partners’ shares from a “hold” to a “sell,” according to The Ledger Gazette. 1. Surgery Partners’ shares opened Nov. 24 trading at $8.60 per share. 2. The ...